Home / See, Read & Share / Federation News

Noa Tishby

Noa Tishby is an Israeli-American performing artist, producer, author and activist. In April 2022, Noa was appointed as Israel’s first-ever Special Envoy for Combating Antisemitism and Delegitimization of Israel.

A Tel Aviv native, Tishby served in the Israeli army before landing a starring role on the nation’s highest-rated prime-time drama, Ramat Aviv Gimmel. After becoming a household name and appearing in numerous TV shows, films, theater productions and fashion campaigns, Tishby moved to Los Angeles where she sold the Israeli TV show In Treatment to HBO which made history as the first Israeli TV show to become an American series. Tishby earned a Peabody Award and Emmy and Golden Globe nominations for her work on the show. She is the founder of “Act for Israel,” Israel’s first online advocacy organization and is the author of Israel: A Simple Guide to the Most Misunderstood Country on Earth.

Diller Teen Fellows Visit Yerucham

Diller Teen Fellows Visit Yerucham

The group of arrived in Federation’s Israeli partner city on for Community Week with 18 of their Yerucham teen peers.

Read More

Don’t Miss Milk & Honey: Sunday, August 23

Don’t Miss Milk & Honey: Sunday, August 23

Register today for this highly popular, family-friendly volunteer opportunity organized by Jewish Community Services of South Florida in partnership with Federation.

Read More

Three Grant Opportunities Now Available

Three Grant Opportunities Now Available

Applications are now being accepted by the Greater Miami Jewish Federation for three 2025 grant opportunities: Women’s Impact Initiative Grants, Jewish Incubator Grants and Israel Engagement & Education Grants.

Read More

July Is Disability Pride Month

July Is Disability Pride Month

July is Disability Pride Month and Federation’s Miami Jewish Abilities Alliance works year-round to celebrate and support Jewish Miamians living with disabilities.

Read More

Stay in Touch

Receive news about Greater Miami Jewish Federation events and more.